Vaccine conjugates comprising a monoclonal antibody binding to human dendritic cells and beta human chorionic gonadotropin

Details for Australian Patent Application No. 2005323472 (hide)

Owner Celldex Therapeutics, Inc.

Inventors Keler, Tibor; Endres, Michael; He, Lizhen; Ramakrishna, Venky

Agent Shelston IP

Pub. Number AU-B-2005323472

PCT Pub. Number WO2006/073493

Priority 10/903,191 30.07.04 US

Filing date 28 July 2005

Wipo publication date 13 July 2006

Acceptance publication date 3 March 2011

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/073493 Priority application(s): WO2006/073493

5 April 2007 Amendment Made

  The nature of the amendment is: Amend the invention title to read Vaccine conjugates comprising a monoclonal antibody binding to human dendritic cells and beta human chorionic gonadotropin 2006

3 March 2011 Application Accepted

  Published as AU-B-2005323472

30 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005323489-Prophylactic and therapeutic uses of FGF-20 in radiation protection

2005323470-System and method for producing chemical or biochemical signals